6
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2804 | Panaxatriol | Panaxtriol | Others |
Panaxatriol (Panaxtriol) can relieve myelosuppression induced by radiation injury. | |||
T3917 | Protopanaxatriol | 20(R)-APPT,20(R)-Protopanaxatriol,(20R)-Protopanaxatriol | PPAR |
Protopanaxatriol (20(R)-APPT), a major ginseng constituent, is a novel PPARγ antagonist. | |||
T2810 | (20S)-Protopanaxatriol | 20(S)-APPT,g-PPT | Apoptosis , Estrogen Receptor/ERR , Glucocorticoid Receptor , Estrogen/progestogen Receptor , Liver X Receptor |
(20S)-Protopanaxatriol (g-PPT)(g-PPT), a metabolite of ginsenoside, could regulate endothelial cell functions through the estrogen receptor and glucocorticoid receptor. | |||
TN2827 | 25(S)-Hydroxyprotopanaxatriol | Others | |
25(S)-Hydroxyprotopanaxatriol is a natural product for research related to life sciences. The catalog number is TN2827 and the CAS number is 113539-03-0. | |||
TN6450 | Quasipanaxatriol | ||
Quasipanaxatriol can greatly enhance the cytotoxicity of the anti-cancer drugs in P388/ADM cells. | |||
T83043 | Anti-MI/R injury agent 1 | ||
Anti-MI/R injury agent 1 (compound 18), derived from Panaxatriol, represents an orally administered, potent agent against myocardial ischemia/reperfusion (MI/R) injury. It improves cell viability in cardiomyocytes subjec... |